122-0551

· Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 122-0551, covering 2018-09-26 to 2018-10-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis [Phase 2]